HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027

Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell ...

Even a slight overproduction of tubulin can tip the balance of cellular health, study shows

For cells to function properly, they must produce the right amount of each protein. It is a delicate balance: Both too little ...
Connecticut Public

Peptides get their regulatory close-up

A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized ...

Immune receptor plays dual role in promoting T-cell exhaustion in cancer

A new Northwestern Medicine study has uncovered how a key immunoregulatory receptor plays an unexpected dual role in ...